ÄÐÈ˹¬µî

Careers Contact Locations

ÄÐÈ˹¬µî.

  • ÄÐÈ˹¬µî
  • Who We Are
    • Our Vision
    • Our History
    • Our Leadership
  • What We Do
    • Overview
    • Our Products
    • Our Solutions
    • Our Technology
    • Our Research
    • Our Diagnostics
  • News & Media
    • Press Releases
    • Announcements
    • Events
    • Presentations
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact
  • Locations

Press Releases

News & Media

News & Media

  • Press Releases
  • Announcements
  • Events
  • Presentations

ÄÐÈ˹¬µî Appoints Katherine Stueland as President and CEO of GeneDx

Jun 22, 2021

BioReference Laboratories Announces First COVID-19 Testing Program for Cruise Industry

Jun 22, 2021

ÄÐÈ˹¬µî to Develop and Commercialize RAYALDEE® in Greater China with Nicoya Therapeutics

Jun 21, 2021

ÄÐÈ˹¬µî Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland

Jun 17, 2021

ÄÐÈ˹¬µî to Participate in the Jefferies Virtual Healthcare Conference

May 27, 2021

ÄÐÈ˹¬µî Reports Transfer of Licensed Rights to RAYALDEE® in Japan to Vifor

May 24, 2021

ÄÐÈ˹¬µî Enters into Exchange Agreements with Certain 4.5% Convertible Senior Noteholders

May 7, 2021

ÄÐÈ˹¬µî Reports 2021 First Quarter Business Highlights and Financial Results

Apr 28, 2021

Major League Soccer Renews with BioReference Laboratories as COVID-19 Testing Provider for Second Year

Apr 27, 2021

ÄÐÈ˹¬µî to Report First Quarter 2021 Financial Results on April 28, 2021

Apr 22, 2021
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...49
    Next

    OPKO HEALTH, INC.
    4400 Biscayne Boulevard
    Miami, FL 33137

    305-575-4100
    contact@opko.com

    © 2023 ÄÐÈ˹¬µî. All Rights Reserved.
    Privacy Policy Governance Terms of Use Sitemap